INTEGRA LIFESCIENCES HOLDINGS CORP Long-Term Debt, Maturity, Year One
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Long-Term Debt, Maturity, Year One of $53.28 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2026-07-29
- 2026-06-30: Long-Term Debt, Maturity, Year One $53.28M.
- 2026-03-31: Long-Term Debt, Maturity, Year One $53.28M.
- 2025-12-31: Long-Term Debt, Maturity, Year One $38.75M.
- 2025-09-30: Long-Term Debt, Maturity, Year One $38.75M.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2026-06-30 | $53.28M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $53.28M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $38.75M 10-K · filed 2026-02-26 |
| 2025-09-30 | $38.75M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $38.75M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $38.75M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $33.91M 10-K · filed 2025-02-25 |
| 2024-09-30 | $33.91M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $33.91M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $33.91M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $14.53M 10-K · filed 2024-02-28 |
| 2023-09-30 | $14.53M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $14.53M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $14.53M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $38.13M 10-K · filed 2023-02-22 |
| 2022-09-30 | $61.88M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $61.88M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $61.88M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $45.00M 10-K · filed 2022-02-24 |
| 2021-09-30 | $45.00M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $45.00M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $45.00M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $33.75M 10-K · filed 2021-02-23 |
| 2020-09-30 | $33.75M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $33.75M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $45.00M 10-K · filed 2020-02-21 |
| 2018-12-31 | $22.50M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |